Japan Pharma Pandemic Impact: Win Some, Lose Some
Mix Varies By Company
Executive Summary
As Japanese pharma companies report quarterly results, the multi-faceted impact of the ongoing coronavirus pandemic on business operations has become clearer. The good news is that it’s been limited so far and the situation has been generally improving.